Pharma Lecture Theatre
The Pharma Lecture Theatre 2018
Including the Pharma Outsourcing Best Practices Panel and the Abou-Gharbia Lecture
This theatre is dedicated to the trends, challenges and outlook of the pharmaceutical industry. You can expect first-hand information on ongoing R&D projects and exchange with leading industry experts.
Look forward especially to Dr Magid Abou-Gharbia, Associate Dean for Research, Director, Moulder Center for Drug Discovery Research and Laura H. Carnell Professor, Temple University, Philadelphia, who will speak exclusively at Chemspec Europe 2018.
The Pharma Outsourcing Best Practices Panel
Chaired by Dr Magid Abou-Gharbia
The session will discuss approaches to developing global outsourcing strategies, identifying outsourcing partners, identifying approaches to mitigate risks, and addressing challenges associated with outsourcing and how to effectively manage partnerships.
The Panel session will be of interest to a wide audience from Pharma, Crop Protection and Chemical companies, CROs and CMOs that are or will be engaged in contract research and custom synthesis of Active Pharmaceutical Ingredients (API).
Chair and moderator
Dr Magid Abou-Gharbia Associate Dean for Research, Director, Moulder Center for Drug Discovery Research and Laura H. Carnell Professor, Temple University, Philadelphia, PA, USA
Speakers - The Pharma Outsourcing Best Practices Panel 2017
- Dr Rudolf Hanko, CEO, Siegfried
- Dr Susan Billings, VP Global Business Development, AMRI
- Dr Robert Waltermire, VP Head, Chemical & Synthetic Development Bristol-Myers Squibb Pharmaceutical Development
- Dr Ramesh Subramanian, VP, Strategic Marketing, Piramal Pharma Solutions
- Christian Jones, Commercial Director, Custom Pharma Solutions, Johnson Matthey
- Dr David Kuo, Senior Director, Global API COE and BU Lead, Patheon
The Abou-Gharbia Lecture
Organised by Dr Magid Abou-Gharbia, Moulder Center for Drug Discovery Research
Drug development in a changing environment: Current challenges and future opportunities
Dr Magid Abou-Gharbia will give a presentation that will cover R&D challenges including drug development cost, attrition rate and pharma new business model aimed at improving attrition rate and improving productivity. Further, he will talk about the impact of generics and personalized medicine on pharma and health care.
Dr Magid Abou-Gharbia
Associate Dean for Research at Temple University
Dr. Abou-Gharbia is currently the Associate Dean for Research, Professor of Medicinal Chemistry and Director of the Moulder Center for Drug Discovery Research (MCDDR) at the School of Pharmacy, Temple University, Philadelphia, PA.
The full programme will be available closer to the event.